Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Portfolio has also been successful in litigation

From the alliacense press release:

More than 75 global, market-leading companies from the US, Europe, Japan, Korea, Taiwan and China have licensed the MMP Portfolio™ technologies, resulting in over $300 million in licensing revenue. The MMP Portfolio has also been successful in litigation, with eight litigants purchasing licenses.

Can someone list the eight?

Share
New Message
Please login to post a reply